Skip to Content

'
Jay B. Shah, MD

Present Title & Affiliation

Primary Appointment

Assistant Professor, Department of Urology, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Education & Training

Degree-Granting Education

2002 Columbia University, New York, NY, MD, Medicine
1998 Harvard University, Cambridge, MA, BA, Magna Cum Laude, Biology

Postgraduate Training

7/2007-6/2010 Clinical Fellowship, Urologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX
7/2006-6/2007 Chief Residency, Urology, Columbia University Medical Center, New York, NY
7/2003-6/2006 Clinical Residency, Urology, Columbia University Medical Center, New York, NY
6/2002-6/2003 Surgical Internship, General Surgery, Columbia University Medical Center, New York, NY

Experience/Service

Institutional Committee Activities

Member, Columbia University Medical Center Department of Urology Resident Education Committee, 2004-2005

Honors and Awards

2008 1st Prize Poster Society of Urological Oncology Annual Meeting
2008 AACR-ASCO Clinical Trial Design Workshop Selectee
2007 AUA Foundation Research Scholar (formerly know as AFUD Scholar)
2007 AUA- New York Section Chief Resident Debate Winner
2007 Ruth L. Kirschstein National Research Service (T32) Grant
2006 Arnold P. Gold Foundation Humanism and Excellence in Teaching Award
2006 Gerald P. Murphey Scholar
2006 Gold Humanism Honor Society Inductee
2006 Peter J. Puchner Resident Teaching Award
2005 2nd Prize NY Academy of Medicine Valentine Essay Contest
2005 CaPSURE Scholar
2004 3rd Prize NY Academy of Medicine Valentine Essay Contest
2003 Physician of Year, Columbia University Medical Center
2002 Alpha Omega Alpha Medical Honor Society Inductee
2002 John K. Lattimer Prize, Awarded to top Urology Student
2001 Lawrence J. Durante Scholarship, Awarded to most well-rounded medical student
2001 Rudin Foundation Award, For academic excellece in medical school
2000 Rudin Foundation Award, For academic excellece in medical school
1999 Charles K. Bacon Memorial Scholarship
1999 Columbia Univeristy College of Physicians & Surgeons Dean's Summer Research Fellowship
1998 Atlantic County Medical Society Scholarship
1998 Atlantic County Medical Society Women's Auxillary Scholarship
1994-1998 Harvard College Dean's List, All semesters
1994-1998 Harvard College Scholarship, All semesters

Professional Memberships

Alpha Omega Alpha Medical Honor Society
Member, 2002-present
American Association of Cancer Research
Member, 2008-present
American Association of Clinical Urologists
Member, 2004-present
American Medical Association
Member, 1998-2002
American Society of Clinical Oncology
Member, 2007-present
American Urological Association
Candidate Member, 2004-present
Arnold P. Gold Humanism Honor Society
Member, 2006-present
Endourological Society
Member, 2006-present
Society of Urological Oncology
Candidate Member, 2007-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Shah JB, Kamat AM. Fluorescence Cystoscopy for Non-muscle Invasive Bladder Cancer. Is The Honeymoon Over for The Blue Light Special? Cancer, 3/2011.
2. Metwalli AR, Kanbolooki S, Jinesh G, Sundi D, Shah JB, Shrader M, Choi W, Lashinger LM, Chunduru S, McConkey DJ, McKinlay M, Kamat A. SMAC mimetic reverses resistance to TRAIL and chemotherapy in human urothelial cancer cells. Cancer Biol Ther, 11/2010.
3. Svatek RS, Shah JB, Xing J, Chang D, Lin J, McConkey DJ, Wu X, Dinney CP. A multiplexed, particle-based flow cytometric assay identified plasma matrix metalloproteinase-7 to be associated with cancer-related death among patients with bladder cancer. Cancer, 10/2010.
4. Shah JB, Margulis V. In search of a better crystal ball: recent advances in prognostic markers for clear-cell renal cell carcinoma. Expert Rev Anticancer Ther 10(6):837-42, 6/2010. PMID: 20553209.
5. McConkey DJ, Choi W, Marquis L, Martin F, Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, Siefker-Radtke A, Dinney C. Role of epithelial-to-mesenchymal transition (EMT) in drug sensitivity and metastasis in bladder cancer. Cancer Metastasis Rev 28(3-4):335-44, 12/2009. PMID: 20012924.
6. Inamoto T, Shah JB, Kamat AM. Friend or foe? Role of peroxisome proliferator-activated receptor-gamma in human bladder cancer. Urol Oncol 27(6):585-91, Nov-Dec, 11/2009. PMID: 19162510.
7. Shah JB, Margulis V. Clinical trials: nationally representative data in urology. Nat Rev Urol 6(7):354-5, 7/2009. PMID: 19578349.
8. Shah JB, McKiernan JM, Elkin EP, Carroll PR, Meng MV, CaPSURE Investigators. Prostate biopsy patterns in the CaPSURE database: evolution with time and impact on outcome after prostatectomy. J Urol 179(1):136-40, 1/2008.
9. Mitchell RE, Shah JB, Desai M, Mansukhani MM, Olsson CA, Benson MC, McKiernan JM. Changes in prognostic significance and predictive accuracy of Gleason grading system throughout PSA era: impact of grade migration in prostate cancer. Urology 70(4):706-10, 10/2007. PMID: 17707892.
10. Shah JB, Whitman C, Lee M, Gupta M. Water under the bridge: 5-year outcomes after percutaneous ablation of obstructing parapelvic renal cysts. J Endourol 21(10):1167-70, 10/2007. PMID: 17949318.
11. Shah JB, Badalato GM, McKiernan JM. New treatments for superficial bladder cancer. Curr Oncol Rep 8(3):201-5, 5/2006. PMID: 16618384.
12. Mitchell RE, Desai M, Shah JB, Olsson CA, Benson MC, McKiernan JM. Preoperative serum prostate specific antigen remains a significant prognostic variable in predicting biochemical failure after radical prostatectomy. J Urol 175(5):1663-7; discussion 1667, 5/2006. PMID: 16600724.
13. Mitchell RE, Shah JB, Olsson CA, Benson MC, McKiernan JM. Does year of radical prostatectomy independently predict outcome in prostate cancer? Urology 67(2):368-72, 2/2006. PMID: 16461087.
14. Shah JB, Fisch H. Controversies in post-vasectomy Management. Contemporary Urology 18(3):40-49, 2006.
15. Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R. Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol 174(3):827-34, 9/2005. PMID: 16093964.
16. Katz MH, Shah JB, Jaffe W, McKiernan JM. Case in Point: Recurrent UTI in a Woman with Post-Void Dribbling. Renal and Urology News, 4/2005.
17. Shah JB, Reese AC, McKiernan JM, Benson MC. PSA updated: still relevant in the new millennium? Eur Urol 47(4):427-32, 4/2005.
18. Shah JB, McKiernan JM. Novel therapeutics in the treatment of bladder cancer. Curr Opin Urol 14(5):287-93, 9/2004. PMID: 15300149.
19. Haddad J, Shah J, Takoudes TG. A survey of US medical education in otolaryngology. Arch Otolaryngol Head Neck Surg 129(11):1166-9, 11/2003. PMID: 14623745.
20. Friedman AD, Shah JB, Takoudes TG, Haddad J. The role of free radicals in chronic rhinosinusitis. Arch Otolaryngol Head Neck Surg 128(9):1055-7, 9/2002. PMID: 12220211.
21. Shah J. Only Time Will Tell: Clock Drawing as an Early Indicator of Neuological Dysfunction. P&S Medical Review 7(2):30-34, 2001.

Book Chapters
1. Gupta M, Ost M, Shah J, McDougal E, Smith A. Percutaneous Management of the Upper Urinary Tract. In: Campbell-Walsh Urology, 9th. Ed(s) Wein AJ. Saunders: Philadelphia, 1526-1564, 2007.
2. Gupta M, Ost M, Shah J, McDougal E, Smith A. Review Questions for Percutaneous Management of the Upper Urinary Tract. In: Campbell-Walsh Urology Study Guide, 9th. Ed(s) Wein AJ. Saunders: Philadelphia, 2007.

Last updated: 2/25/2013